Estimates Revisions Sensorion

Stocks

Market Closed - Euronext Paris 16:55:00 26/08/2026 BST			Pre-market 06:30:21
0.2730 ^EUR	-1.80%		0.2740	+0.37%

06-11	Sensorion continues its decline despite Stifel's positive outlook
06-10	Sensorion Achieves Key Regulatory Milestones for Sens-601 for Gjb2-Related Hearing Loss and Selects Program as Lead Gene Therapy Candidate	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	SENSORION
	LONZA GROUP AG
	REVOLUTION MEDICINES, INC.
	BEONE MEDICINES AG
	IQVIA HOLDINGS INC.
	CELLTRION, INC.
	MEDPACE HOLDINGS, INC.
	ASCENDIS PHARMA A/S			-
	EUROFINS SCIENTIFIC SE
	CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
	Average
	Weighted average by Cap.